Atlanta, GA, United States of America

Roger Michael Hendry

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Wyeth. Active years: 2012-2014.


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Warwick, NY (US) (2012)
  • Atlanta, GA (US) (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Roger Michael Hendry

Introduction

Roger Michael Hendry is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of virology, particularly in the development of immunogenic compositions. With a total of 2 patents, his work focuses on enhancing the safety and efficacy of viral vectors.

Latest Patents

Hendry's latest patents include the invention titled "Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof." This invention broadly relates to the synergistic attenuation of vesicular stomatitis virus (VSV). More particularly, it involves the identification of combined mutation classes that synergistically reduce the pathogenicity of VSV vectors in mammals, along with the associated immunogenic compositions.

Career Highlights

Throughout his career, Hendry has been associated with Wyeth, a prominent company in the pharmaceutical industry. His innovative work has contributed to advancements in vaccine development and viral vector technology.

Collaborations

Hendry has collaborated with notable professionals in his field, including David Kirkwood Clarke and Stephen Alexander Udem. These collaborations have further enriched his research and development efforts.

Conclusion

Roger Michael Hendry's contributions to the field of virology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in immunogenic compositions and viral vector technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…